Trial Profile
Synergistic Effect of Simvastatin and Ezetimibe on Lipid and Pro-inflammatory Profiles in Pre-diabetic Subjects.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Simvastatin (Primary)
- Indications Atherosclerosis; Hypercholesterolaemia; Insulin resistance
- Focus Pharmacodynamics
- 19 Apr 2010 New trial record